Georgetown University Med Ctr

Washington D.C., District of Columbia 20007

0 studies enrolling now · 3 studies all time

What they study most

Esophageal Cancer, Melanoma, Myeloid Leukemia, Chronic, Chronic-Phase

Studies at this site

• Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer — Completed
• An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma — Completed
• Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML — Completed